Immediate Postpartum Breastfeeding following Pregnancy with Cardiac Disease

Abstract

Objective This study aimed to identify predictors of immediate postpartum breastfeeding among women with maternal cardiac disease (MCD).

Study Design This study included all gravidas with MCD who delivered at a single institution from 2012 to 2018. Charts were abstracted for maternal demographics, obstetrical outcome, cardiac diagnoses, cardiac risk stratification scores, and prepregnancy echocardiogram findings. Kruskal–Wallis and Fisher's exact tests were used to compare the breastfeeding (BF) group versus the nonbreastfeeding (NBF) group. Logistic regression was used to obtain odds ratios (ORs) with 95% confidence intervals (CIs).

Results Among 211 gravidas with MCD, 12% were not breastfeeding at the time of postpartum hospital discharge. Compared with the BF group, the NBF group had a significantly higher proportion of women with cardiomyopathy (21% NBF vs. 7% BF, OR = 3.44, 95% CI: 1.12–10.71), with modified World Health Organization (WHO) classification ≥III (33 vs. 14%, OR = 3.16, 95% CI: 1.22–8.15), and with prepregnancy ejection fraction (EF) < 50% (55 vs. 14%, OR = 7.20, 95% CI: 1.92–27.06). There were otherwise no differences between the two groups with regards to other cardiac diagnoses or cardiac risk scores.

Conclusion In women with MCD, cardiomyopathy, modified WHO class ≥III, and a prepregnancy EF < 50% were associated with NBF in the immediate postpartum period. These findings may guide providers in identifying a subset of women with MCD who can benefit from increased breastfeeding counseling and support.

Key Points

• Eighty-two percent of patients with cardiac disease are breastfeeding at the time of postpartum discharge.

• Cardiomyopathy is associated with an increased odds of not breastfeeding at postpartum discharge.

• Rationale for not breastfeeding is infrequently documented in the medical record.

Keywords

maternal cardiac disease - breastfeeding initiation - lactation - postpartum care

Note

This work was accepted as a poster abstract for the Sixth International Congress on Cardiac Problems in Pregnancy in 2020, which was cancelled due to the COVID-19 pandemic.

Publikationsverlauf

Eingereicht: 07. Dezember 2022

Angenommen: 28. Januar 2024

Artikel online veröffentlicht:
19. Februar 2024

• References

• 1 Kovacs AH, Harrison JL, Colman JM, Sermer M, Siu SC, Silversides CK. Pregnancy and contraception in congenital heart disease: what women are not told. J Am Coll Cardiol 2008; 52 (07) 577-578
• 2 American College of Obstetricians and Gynecologists' Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins—Obstetrics. Practice Bulletin No 212: Pregnancy and heart disease. Obstet Gynecol 2019; 133 (05) e320-e356
• 3 U.S. Breastfeeding Committee. Healthy People 2020: Breastfeeding Objectives. 2020 . Accessed on April 18, 2021 at: http://www.usbreastfeeding.org/p/cm/ld/fid=221
• 4 Meek JY, Noble L. Section on Breastfeeding. Policy statement: breastfeeding and the use of human milk. Pediatrics 2022; 150 (01) e2022057988
• 5 Ricke-Hoch M, Pfeffer TJ, Hilfiker-Kleiner D. Peripartum cardiomyopathy: basic mechanisms and hope for new therapies. Cardiovasc Res 2020; 116 (03) 520-531
• 6 Sliwa K, Hilfiker-Kleiner D, Petrie MC. et al; Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010; 12 (08) 767-778